First-in-Human trial begins for potential Gout-Preventing injection
NCT ID NCT06859073
Summary
This is the first time a new drug called NNC4004-0002 is being given to people. The study aims to see if it is safe and how well the body tolerates it in adults with high uric acid levels but no symptoms. Researchers will also check if a single injection can lower uric acid in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PAREXEL Glendale/LA EPCU
NOT_YET_RECRUITINGGlendale, California, 91206, United States
-
PAREXEL Intl - EPCU-Baltimore
RECRUITINGBaltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.